PRESS RELEASE published on 10/21/2024 at 14:30, 1 year 9 months ago Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024 Inventiva announces late breaker abstract from LEGEND Phase 2 trial evaluating lanifibranor with empagliflozin in MASH at AASLD The Liver Meeting® 2024 Inventiva MASH Lanifibranor LEGEND Phase 2 Empagliflozin
PRESS RELEASE published on 10/21/2024 at 14:30, 1 year 9 months ago XS Financial Expands Into Middle-Market Equipment Finance, Establishing Buy-Side Capital Markets Desk XS Financial announces strategic expansion into mid to large-ticket transactions in middle-market equipment leasing sector. Acquired by Axar and Mavik, enhancing financial strength and flexibility Expansion Capital Markets Equipment Finance XS Financial Middle-Market
PRESS RELEASE published on 10/21/2024 at 14:30, 1 year 9 months ago LQR House Inc. Implements Strategic Cost-Cutting Measures Under Activist Investor David Lazar's Leadership LQR House Inc. announces strategic updates including shutting down RareSips NFT platform and ending Bevage LLC partnership under new Director David Lazar to enhance operational efficiency and shareholder value LQR House Inc. Operational Efficiency Shareholder Value Strategic Updates David Lazar
PRESS RELEASE published on 10/21/2024 at 14:30, 1 year 9 months ago Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO Catheter Precision announces publication on non-invasive ablation technique STAR for cardiac electrophysiology. VIVO technology shows promising results in targeting heart arrhythmia areas Catheter Precision Cardiac Electrophysiology VIVO Technology STAR Ablation Technique
PRESS RELEASE published on 10/21/2024 at 14:25, 1 year 9 months ago Director/PDMR Shareholding Britvic plc Directors purchase shares and receive matching shares under Share Incentive Plan. Details of transactions and interests disclosed Transactions Share Incentive Plan Britvic Plc Directors Matching Shares
PRESS RELEASE published on 10/21/2024 at 14:15, 1 year 9 months ago Quant Tekel: Defining the Future of Trading Quant Tekel revolutionizes brokerage and prop trading with cutting-edge technology, unmatched experience, and top-tier support for traders, offering opportunities for success and personal growth Cutting-edge Technology Financial Markets Brokerage Prop Trading Quant Tekel
PRESS RELEASE published on 10/21/2024 at 14:01, 1 year 9 months ago Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update Mainz Biomed reports 4% revenue increase in Mid-Year 2024 Financial Results with 32% decrease in loss from operations. Company highlights successful studies at ASCO and outlines strategic plan for 2025 Financial Results Corporate Update ColoAlert Mainz Biomed EAArly DETECT
PRESS RELEASE published on 10/21/2024 at 14:00, 1 year 9 months ago CANEX Increases Equity Financing CANEX Metals Inc. announces increase in non-brokered private placement to offer up to 3,000,000 Common Shares and 5,250,000 FT Shares for a total of $450,000. Funds to be used for exploration and project advancement Private Placement TSX Venture Exchange Exploration CANEX Metals Inc. Shareholder Demand
PRESS RELEASE published on 10/21/2024 at 13:30, 1 year 9 months ago MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study MIRA Pharmaceuticals, Inc. announces promising results for novel oral ketamine analog Ketamir-2 in providing superior pain relief compared to current treatments. Preparing for Phase 1 clinical trials and exploring potential in PTSD Clinical Trials PTSD MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain
PRESS RELEASE published on 10/21/2024 at 13:23, 1 year 9 months ago EQS-Adhoc: Basler AG: Basler AG reports preliminary 9-month figures: sales decrease by 13% to EUR 136.8 million, EBITDA increases by over 100% to EUR 9.0 million. Organization and forecast adjustments due to lack of market recovery Preliminary Results Basler AG Sales Decrease 9-month Figures Forecast Adjustments
Published on 08/20/2026 at 00:40, 25 minutes ago Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/19/2026 at 22:00, 3 hours 5 minutes ago Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/19/2026 at 20:35, 4 hours 30 minutes ago Revive Therapeutics Announces Proposed Shares for Debt Settlement
Published on 08/19/2026 at 18:50, 6 hours 15 minutes ago AmeriTrust Auto Advances End-to-End Lease Remarketing Strategy
Published on 08/19/2026 at 16:00, 9 hours 5 minutes ago Telefónica Chile and Amdocs Establish Strategic Multi-Year Agreement to Accelerate Modernization and Business Agility in Chile
Published on 08/19/2026 at 16:51, 8 hours 14 minutes ago AUTODOC and Apollo Funds successfully conclude transformative partnership
Published on 08/19/2026 at 16:15, 8 hours 50 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/18/2026 at 11:15, 1 day 13 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 5 hours ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 08:33, 2 days 16 hours ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
Published on 08/17/2026 at 07:30, 2 days 17 hours ago Disclosure of transactions in own shares from August 10 to August 14, 2026